NEWTEKONE INC

Company Overview

NewtekOne is a technology-enabled financial holding company that provides integrated business and financial services to small and mid-size businesses, with a heavy emphasis on SBA lending (7(a) and 504), ALP/non‑conforming commercial loans, payments, servicing and ancillary products (payroll, insurance brokerage). SBA 7(a) origination and the sale of guaranteed portions (while retaining unguaranteed tranches and servicing) are a material revenue driver — the bank originated $943M of SBA 7(a) loans in 2024 and as of Feb 2025 was the largest SBA 7(a) lender by dollar approvals. The firm is alliance‑centric and digitally driven (patented NewTracker referral platform), funds balance‑sheet growth through deposits, warehouse/JV structures and periodic ALP securitizations, and is subject to tight regulatory oversight as an FHC with OCC/Fed commitments and PLP dependencies. Recent results show rapid balance‑sheet growth, increased noninterest income from loan sales and servicing (and a large ALP residual gain in 2025), but also higher provisions, rising nonperforming assets (4.6% at year‑end 2024; 5.8% at mid‑2025) and CECL‑sensitive allowances.

Executive Compensation Practices

Compensation is likely driven toward origination volumes, fee and servicing income, successful loan‑sale/securitization execution (which produce large one‑time premiums/residual gains), deposit growth and capital/ liquidity metrics given regulatory floors under the OCC/Fed agreements. Because Newtek’s earnings mix is weighted toward noninterest income (loan sale premiums, servicing and payments revenue), executive bonuses and short‑term incentives may disproportionately reward origination and securitization timing; committees will therefore typically offset that with multi‑year performance criteria tied to credit quality (NPA levels, CECL provisioning), ROA/ROE, efficiency ratios and regulatory compliance. As a regulated bank/FHC, the company is also likely to use deferrals, clawback/malus provisions and risk‑adjusted vesting to align pay with long‑term capital adequacy and to satisfy Fed/OCC guidance; the recent conversion to an FHC and the NTS divestiture may have already altered equity grant sizes or vesting treatment. Expect equity‑based pay and cash bonuses to reflect quarter‑to‑quarter variability from sale timing, so boards should emphasize multi‑period metrics to avoid encouraging excessive originations at the expense of asset quality.

Insider Trading Considerations

Insiders at Newtek will have particularly high informational visibility into origination pipelines, upcoming loan sales/securitizations (which can generate material gains), servicing residuals and deposit/liquidity positions — all of which can produce sharp, discrete moves in quarterly results. Watch for clustered insider sales or option exercises following announced ALP securitizations or large SBA sale transactions (these events can create opportunity for insiders to monetize windfalls), and compare the timing of trades to disclosure windows and any disclosed 10b5‑1 plans. Regulatory and supervisory constraints (OCC/Fed operating agreement, PLP reliance) increase the sensitivity of company valuation to adverse regulatory news; that can lead insiders to be more conservative in open‑market trades and more likely to use pre‑planned disposition mechanisms or to delay transactions until after public filings. For monitoring, contrast insider selling activity against credit deterioration signals (rising NPAs, higher CECL reserves) — elevated insider selling amid worsening asset quality warrants closer scrutiny.